Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2464853015 | Epidermal growth factor receptor inhibitor (substance) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 2471188018 | Epidermal growth factor receptor inhibitor | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 2477410016 | EGFR inhibitor | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT core module |
| 3520637019 | Epidermal growth factor receptor antagonist | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3520734017 | Substance with epidermal growth factor receptor antagonist mechanism of action (substance) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3520904018 | Substance with epidermal growth factor receptor antagonist mechanism of action | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3637366018 | EGFR antagonist | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT core module |
| 4589761011 | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4589762016 | EGFR (epidermal growth factor receptor) inhibitor | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Is a | Antineoplastic agent | true | Inferred relationship | Existential restriction modifier | ||
| Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Is a | Substance with protein-tyrosine kinase inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Has disposition | Epidermal growth factor receptor inhibitor | true | Inferred relationship | Existential restriction modifier | ||
| Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Is a | Substance categorized by disposition | false | Inferred relationship | Existential restriction modifier | ||
| Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Is a | Substance with receptor antagonist mechanism of action (substance) | false | Inferred relationship | Existential restriction modifier | ||
| Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Is a | Substance with enzyme inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Is a | Substance with protein kinase inhibitor mechanism of action | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cetuximab | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Has active ingredient | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | 1 |
| Substance with protein-tyrosine kinase inhibitor mechanism of action | Is a | False | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Panitumumab | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Osimertinib | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Necitumumab | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Nimotuzumab | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Osimertinib mesilate | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Gefitinib | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Erlotinib hydrochloride | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Erlotinib | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Lapatinib | Is a | False | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Lapatinib ditosylate | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Vandetanib | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Lapatinib ditosylate monohydrate | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Substance with human epidermal growth factor receptor 2 inhibitor mechanism of action (substance) | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Amivantamab | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | |
| Disorder of skin caused by epidermal growth factor receptor inhibitor | Causative agent | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier | 1 |
| Mobocertinib | Is a | True | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR